COVID-19 infection and risk of adverse drug reactions: Cohort study
In this study, the incidence rate in hospitalized patients with COVID-19 was not statistically different from that in the group with another infection. High CRP levels, as well as low eGFR, were the main risk factors for the occurrence of ADRs and should be considered in further ADR prevention strategies.
Authors
- Marie‐Noëlle Beyens (ORCID: https://orcid.org/0000-0002-5831-8957)
- Marlène Damin‐Pernik (ORCID: https://orcid.org/0000-0001-5076-0698)
- Florelle Bellet (ORCID: https://orcid.org/0000-0002-0400-2586)
- Manon Launay (ORCID: https://orcid.org/0000-0003-3113-7301)
- Amandine Gagneux-Brunon
- Paul-Benoît Fargier
Institutions
- Inserm (FR)
- Hôpital Nord (FR)
- Centre Hospitalier Universitaire de Saint-Étienne (FR)
Publication Details
- Journal
- Therapies
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1016/j.therap.2024.12.012
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00